Cerebral embolic shower secondary to BioGlue use in triple valve surgery

Indian J Thorac Cardiovasc Surg. 2022 Jul;38(4):426-429. doi: 10.1007/s12055-022-01344-z. Epub 2022 Mar 30.

Abstract

Hemostasis is a crucial step in cardiac surgery which determines postoperative outcomes. Tissue sealants and glues are necessary to achieve hemostasis in situations where conventional methods are unsuccessful. BioGlue, a commonly used topical hemostatic agent, has been reported to cause systemic embolic complications. We report a case of cerebral embolic shower following the use of BioGlue for posterior aortic suture line bleeding in a 49-year-old lady who underwent triple valve surgery. This report brings to light a rare but devastating complication of BioGlue usage in the present era of complex aortic surgeries. We also postulate a mechanism for BioGlue embolization.

Keywords: BioGlue embolism; Glues; Stroke; Tissue sealants.

Publication types

  • Case Reports